04.10.2007 13:00:00
|
Millennium Cell Announces Key Initiatives
Millennium Cell Inc. (NASDAQ:MCEL)
announced today that it has undertaken a number of key initiatives to
position the Company for future growth. The Board of Directors has
established an advisory board for the purpose of promoting the
widespread adoption of the Company’s hydrogen
battery technology by U.S. Government agencies. The advisory board
consists of former senior U.S. Government officials and policy makers,
including:
L.J. Evans, Jr. (Chairman) - Principal and CEO of SFI Financial Group
and Company Board member
Former Chairman of White House Cabinet Council on Technology
Commercialization
Served as Head of NASA Commercial Technology
Former member of the National Research Council Applications Board
Joe N. Austin, Jr. – Principal and CEO,
Government Marketing and Procurement LLC
Former Assistant and Legislative Liaison Officer for the Secretary of
the Army
Retired Army Officer with 21 year career in Aviation, Armor,
Intelligence, Legislative Liaison
Member of Gartner Information Technology Federal Advisory Board
Dr. Ronald Blanck, D.O. – President of the
University of North Texas Health Science Center at Fort Worth, Lt.
General US Army (Ret.)
Former Surgeon General of the US Army & Commander of the US Army
Medical Command
Served as Commander of Walter Reed Medical Center North Atlantic Region
Chairs task forces on bioterrorism for both the Texas Medical
Association and the American Osteopathic Association
Dr. Jacques S. Gansler, PhD – Vice
President of Research, University of Maryland
Director of the Center for Public Policy and Private Enterprise
Served as Under Secretary of Defense for Science, Technology and
Acquisition
Former Deputy Assistant Secretary of Defense
Dr. Charles Harvey Roadman II, MD, CNA –
Lt. General USAF (Ret.)
Former President and CEO American Care Health Association
Served as Surgeon General for the US Air Force
Managed health services to 2.4 million beneficiaries
"Our ability to attract such talented and
influential individuals to our new advisory board is a testament to the
potential of Millennium Cell’s products. With
the help of this group, we fully expect to expand the awareness and
accelerate the adoption of hydrogen battery products in the U.S.
military and with other governmental customers,”
said H. David Ramm, CEO, Millennium Cell.
The Company has also engaged Collins Stewart LLC (formerly C.E.
Unterberg, Towbin LLC), the U.S. affiliate of Collins Stewart plc, as
financial advisor and investment banker for potential acquisitions and
partnering activities and they may also assist the Company with respect
to future underwritten and private placement financing activities.
Collins Stewart is a global investment bank, headquartered in London,
which specializes in raising capital for small and mid-cap companies,
particularly in the technology, life science and defense sectors.
The Company has signed a retention agreement with John D. Giolli, its
Chief Financial Officer. This action, together with the letter agreement
executed with Adam P. Briggs, Millennium Cell President in March 2007,
are the first of several actions the Company may take to provide for
continuity of key employees. A Current Report on Form 8-K will be filed
later today with the Securities and Exchange Commission describing the
terms of the agreement with Mr. Giolli and with members of the advisory
board.
"We are convinced that hydrogen batteries
will provide users with significant performance and cost benefits over
alternative power source solutions for a variety of applications. This
series of proactive actions reassert the commitment and desire of the
Board of Directors and management to realize the value inherent in our
technology and to deliver it to our shareholders. With Collins Stewart,
we are actively pursuing near-term strategic acquisition and partnering
opportunities that can help accelerate the launch of Millennium Cell
power source products and provide the Company with more control over
product development activities,” commented
Mr. Ramm.
"One of our immediate priorities is to
maintain our Nasdaq market listing. If we do not regain compliance with
the minimum bid price requirement of $1.00 before October, 22nd
and we are not eligible for the additional 180 day grace period,
we plan to request a hearing at which a Nasdaq panel will determine,
based upon the plan we present, whether or not to grant us additional
time to regain compliance with applicable Nasdaq listing requirements.
Until a decision is made by the Nasdaq panel, our Nasdaq listing will
continue uninterrupted. We want to thank our shareholders for their
continued support and look forward to updating you shortly on our
progress, "concluded Mr. Ramm.
About Millennium Cell
Millennium Cell is a leader in the development of hydrogen battery
technology used to power portable applications. Through its proprietary
Hydrogen on Demand®
fuel cartridges and PowerSkin™ fuel cell
modules, the Company provides increased energy density resulting in
longer runtime and lighter weight in a compact space. The Company is
working with market partners to meet the demand for a better battery in
the military, medical, industrial and consumer electronics markets. For
more information, visit www.millenniumcell.com.
Cautionary Note Regarding
Forward-looking Statements: This press release may include statements that are not historical
facts and are considered ``forward-looking”
within the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements reflect Millennium Cell’s
current views about future events and financial performance and are
subject to risks. Forward-looking statements are identified by
their use of terms and phrases such as "believe,” "expect,” "plan,” "anticipate,” "on
target” and similar expressions identifying
forward-looking statements. Investors should not rely on
forward-looking statements because they are subject to a variety of
risks, uncertainties and other factors, many of which are outside of our
control, that could cause actual results to differ materially from
Millennium Cell’s expectations, and
Millennium Cell expressly does not undertake any duty to update
forward-looking statements. These factors include, but are not
limited to, the following: (i) the cost and timing of development and
market acceptance of Millennium Cell’s
hydrogen fuel storage and delivery system; (ii) the cost and commercial
availability of the quantities of raw materials required by the hydrogen
fuel storage and delivery systems; (iii) competition from current,
improving and alternative power technologies; (iv) Millennium Cell’s
ability to raise capital at the times, in the amounts and at the costs
and terms that are acceptable to fund the development and
commercialization of its hydrogen fuel storage and delivery system and
its business plan; (v) Millennium Cell’s
ability to protect its intellectual property; (vi) Millennium Cell’s
ability to achieve budgeted revenue and expense amounts; (vii)
Millennium Cell’s ability to generate
revenues from the sale or license of, or provision of services related
to, its technology; (viii) Millennium Cell’s
ability to form strategic alliances or partnerships to help promote our
technology and achieve market acceptance; (ix) Millennium Cell’s
ability to generate design, engineering or management services revenue
opportunities in the hydrogen generation or fuel cell markets; (x)
Millennium Cell’s ability to secure
government funding of its research and development and technology
demonstration projects; and (xi) other factors discussed under the
caption "Investment Considerations”
in Millennium Cell’s Annual Report on Form
10-K for the year ended December 31, 2006.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Millennium Cell Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Millennium Cell Inc.mehr Analysen
Aktien in diesem Artikel
Millennium Cell Inc. | 0,00 | 0,00% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 218,17 | 0,83% |